Formulated fibrillar type 1 collagen (2.6%) derived from bovine skin

Formulated fibrillar type 1 collagen (2.6%) derived from bovine skin

 

A 3-dimensional flowable dermal matrix for immediate activation of PDGF upon application to acute and chronic wounds.

 
 
 

Product Description

Excellagen is for use by healthcare professionals in the United States.
 Excellagen Activates Platelets Triggering Release of PDGF Key Wound Healing Growth Factors. (US Patent issued 10/7/20172017)

Excellagen Activates Platelets Triggering Release of PDGF Key Wound Healing Growth Factors. (US Patent issued 10/7/20172017)

  • Excellagen is an FDA-cleared aseptically-manufactured, syringe-based, ready to use topical flowable 3-dimensional dermal matrix that supports a favorable wound healing environment.

  • It is designed to accelerate granulation tissue growth by providing a structural scaffold for cellular migration and proliferation, and activates platelets, triggering the localized release of endogenous growth factors including Platelet-Derived Growth Factor (PDGF), a key biological mediator of wound healing.

  • Upon contact with small amounts of blood, Excellagen immediately activates the expression of PDGF essential to activating the healing process.

INDICATIONS FOR USE:
Excellagen is indicated for the management of wounds including: partial and full-thickness wounds, pressure ulcers, venous ulcers, diabetic ulcers, chronic vascular ulcers, tunneled/undermined wounds, surgical wounds (donor sites/graft, post-Mohs surgery, post-laser surgery, podiatric, wound dehiscence), trauma wounds (abrasions, lacerations, second-degree burns and skin tears) and draining wounds.

Excellagen should not be used in individuals with a known sensitivity to bovine collagen.

excellagen_07340_sm.jpg